Complement system studies in systemic lupus erythematosus (SLE)
Complement system involvement has been studied in 16 patients with systemic lupus erythematosus (SLE). Circulating conversion products of C3 were observed in 4 cases. Low mean values of C4 and C3 were found, while C3 proactivator (properdin factor B) levels were low in only a few of the patients. The levels of C4, C3 and C3 proactivator were not lower in the 4 patients in whom C3 conversion products could be demonstrated than in the others. It is concluded that the low complement values found in SLE may be caused mainly by deficient synthesis. Signs of complement activation are in this patient material demonstrated early in the disease, and chiefly in patients not receiving immunosuppressive therapy.
D000293:Adolescent; D000328:Adult; D000818:Animals; D001379:Azathioprine / Q000627:therapeutic use; D003165:Complement System Proteins / Q000032:analysis*; D005260:Female; D006801:Humans; D007106:Immune Sera; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009504:Neutrophils; D011241:Prednisone / Q000627:therapeutic use; D011414:Properdin / Q000032:analysis; D011485:Protein Binding; D011817:Rabbits / Q000276:immunology
D007106:Immune Sera; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D011414:Properdin; D003165:Complement System Proteins; D001379:Azathioprine; D011241:Prednisone